Characteristics of apparently false-negative digene hybrid capture 2 high-risk HPV DNA testing

American Journal of Clinical Pathology

Volumn 125, Issue 2, 2006, Pages 223-228

  Jastania, Raid ^a   Geddie, William R ^a   Chapman, William ^a   Boerner, Scott ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cervical dysplasia; Human papillomavirus; Hybrid Capture; Squamous intraepithelial lesion

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER GRADING; CANCER SCREENING; COLPOSCOPY; DEVICE; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; HIGH RISK HYBRID CAPTURE 2 TEST; HUMAN; HUMAN CELL; LABORATORY DIAGNOSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

EID: 31544443821     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/QEJBYT77YMTEVJ66     Document Type: Article

References (12)

1. Solomon D. Chapter 14: role of triage testing in cervical cancer screening. J Natl Cancer Inst Monogr. 2003;31:97-101.
2. Iftner T, Villa LL. Chapter 12: human papillomavirus technologies. J Natl Cancer Inst Monogr. 2003;31:80-88.
3. Zielinski GD, Bais AG, Helmerhorst TJ, et al. HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis. Obstet Gynecol Surv. 2004;59:543-553.
4. Kulmala SM, Syrjanen S, Shabalova I, et al. Human papillomavirus testing with the Hybrid Capture 2 assay and PCR as screening tools. J Clin Microbiol. 2004;42:2470-2475.
5. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293-299.
6. INK4a and Hybrid Capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia. Am J Clin Pathol. 2004;122:894-901.
7. de Cremoux P, Coste J, Sastre-Garau X, et al. Efficiency of the Hybrid Capture 2 HPV DNA test in cervical cancer screening: a study by the French Society of Clinical Cytology. Am J Clin Pathol. 2003;120:492-499.
8. Lonky NM, Felix JC, Naidu YM, et al. Triage of atypical squamous cells of undetermined significance with Hybrid Capture II: colposcopy and histologic human papillomavirus correlation. Obstet Gynecol. 2003;101:481-489.
9. Lorincz AT, Castle PE, Sherman ME, et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet. 2002;360:228-229.
10. Sherman ME, Wang SS, Wheeler CM, et al. Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions. Cancer Epidemiol Biomarkers Prev. 2003;12:1038-1044.
11. Schiffman MH, Kiviat NB, Burk RD, et al. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol. 1995;33:545-550.
12. Castle PE, Wheeler CM, Solomon D, et al. Interlaboratory reliability of Hybrid Capture 2. Am J Clin Pathol. 2004;122:238-245.